United States

Choose your country or region:

DIGITAL NEWSROOM

Posts in: Investor Relations

May 09, 2023

Exact Sciences Announces First Quarter 2023 Results
February 21, 2023

Exact Sciences Announces Fourth Quarter 2022 Results
January 08, 2023

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results
November 03, 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability
October 24, 2022

Exact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting
April 28, 2017

Cologuard growth accelerates to $48.4 million in revenue during first quarter; volume grows 150 percent year over year to 100,000 completed tests
October 03, 2016

What Cologuard's Inclusion in HEDIS Means
June 20, 2016

A Letter To Our Shareholders
May 03, 2016

Exact Sciences Completes 40,000 Cologuard Tests During First Quarter 2016
February 25, 2016

Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service
February 23, 2016

Modeling Data Supports Cologuard Use Every Three Years
January 25, 2016

Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors